[#item_full_content] Business of Cannabis spoke with Stefan Adomeit, Co-Founder and Managing Director of Remexian Pharma GmbH, one year on from High Tide’s acquisition of a majority stake in the German medical cannabis wholesaler. Adomeit reports orders up approximately 50% since the transaction, and discusses Remexian’s resilience through Germany’s recent decision to end statutory health insurance reimbursement 
Read More
Business of Cannabis: Remexian Surging Ahead One Year On From High Tide Purchase
ByPot Shop News
August 27, 2026